Pharmaceutical Stability And Storage Services Market Revenue Projected To Hit $2.36 Billion By 2030 With 17.5% CAGR
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
From Its 2026 Market Size, What Value Is The Pharmaceutical Stability And Storage Services Market Projected To Reach By 2030?
The pharmaceutical stability and storage services market size has experienced robust expansion in recent years. This market is set to increase from $2.81 billion in 2025 to $2.99 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.1%. The growth observed in prior periods is attributable to stringent pharmaceutical regulatory requirements, a rise in global drug production, the expansion of biologics manufacturing, the demand for shelf-life validation, and growing clinical trial volumes.
The market for pharmaceutical stability and storage services is projected to experience robust expansion in the coming years. This market is anticipated to reach $3.78 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.1%. Factors contributing to this growth during the forecast period include the increasing development of biologics and cell therapies, a rise in pharmaceutical outsourcing, the expansion of the global cold chain infrastructure, augmented vaccine production, and more stringent regulatory oversight concerning drug stability. Key trends expected within this period encompass a heightened demand for storage that complies with regulations, an increase in the outsourcing of stability testing, a growing requirement for cold chain and cryogenic storage solutions, the broadening of stability services specifically for biologics, and an intensified focus on ensuring the long-term quality of pharmaceutical products.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=23473&type=smp
What Factors Are Contributing To The Growth Of The Pharmaceutical Stability And Storage Services Market?
The pharmaceutical stability and storage services market is anticipated to experience growth due to the escalating number of novel drug approvals. A novel drug refers to a pharmaceutical compound that has been newly created and has not previously been approved for application or commercialized. The increasing frequency of novel drug approvals results from advancements in biotechnology, which facilitate the discovery of new compounds, as well as enhanced regulatory processes that promote quicker, more streamlined drug development. This rise in novel drug approvals stimulates the need for pharmaceutical stability and storage services, which are essential for ensuring optimal conditions, adherence to regulations, and effective management of extended shelf-life. For instance, in October 2023, according to the U.S. Food and Drug Administration (FDA), a US-based federal agency responsible for protecting public health, 37 novel drugs received approval in 2022, with 50 projected for 2024. These approvals are advancing therapies for conditions including cancer, rare diseases, neurology, infections, and specific ailments like schizophrenia, pain, and Alzheimer’s. Therefore, the growing number of novel drug approvals is propelling the expansion of the pharmaceutical stability and storage services market.
What Are The Different Segment Types In The Pharmaceutical Stability And Storage Services Market Segment Breakdown?
The pharmaceutical stability and storage services market covered in this report is segmented –
1) By Service: Stability, Storage
2) By Product Type: Tablets, Capsules, Injectable Solutions, Oral Suspensions, Combination Products, Other Product Types
3) By Molecule: Small Molecule, Large Molecule
4) By Mode: In-House, Outsourcing
5) By End User: Biopharmaceutical Companies, Contract Manufacturing Organizations, Contract Research Organizations, Other End Users
Subsegments:
1) By Stability Services: Long-Term Stability Studies, Accelerated Stability Studies, Intermediate Stability Studies, Photostability Testing, Forced Degradation Studies
2) By Storage Services: Ambient Storage, Refrigerated Storage (2°C to 8°C), Frozen Storage (-20°C to -80°C), Cryogenic Storage (-150°C to -196°C), Controlled Drug Substance And Product Storage
Which Trends Are Impacting The Progress Of The Pharmaceutical Stability And Storage Services Market?
Key companies in the pharmaceutical stability and storage services market are concentrating on developing advanced technological solutions, notably cryogenic storage suites, to improve the preservation of temperature-sensitive pharmaceutical goods. These specialized cryogenic storage facilities are engineered to maintain exceptionally low temperatures, typically below -150°C, crucial for safeguarding delicate biological and pharmaceutical materials like cell therapies, vaccines, and biologics. As an example, in December 2024, Astoriom, a UK-based entity in the stability and biospecimen storage sector, introduced a cryogenic storage suite at its Tramore facility in County Waterford, Ireland, significantly broadening its capacity for biological sample storage. This cutting-edge suite is configured to address the rising need for secure, long-term preservation of biological materials, assuring their viability for extended durations. The storage system boasts precise temperature regulation to -196°C, substantial storage volume, ISO 9001 certification for compliance, and sophisticated security arrangements, including controlled access and monitoring.
Who Are The Well-Known Companies In The Pharmaceutical Stability And Storage Services Market?
Major companies operating in the pharmaceutical stability and storage services market are SGS S.A., Eurofins Scientific SE, Intertek Group plc, Catalent Inc., Almac Group, Alcami Corporation, Reading Scientific Services Ltd., Charles River Laboratories, Element Materials Technology Inc., Precision Stability Storage, Roylance Stability Storage Limited, BioLife Solutions Inc., Alloga UK Ltd., Auriga Research Private Limited, Q Laboratories Inc., ALS Limited, Lucideon Limited, Cencora Inc., PCI Pharma Services, DHL Life Sciences & Healthcare
Get The Full Pharmaceutical Stability And Storage Services Market Report:
Which Region Represents The Largest Share Of The Pharmaceutical Stability And Storage Services Market?
North America was the largest region in the pharmaceutical stability and storage services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical stability and storage services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Pharmaceutical Stability And Storage Services Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Pharmaceutical Stability And Storage Services Market 2026, By The Business Research Company
Pharmacy Repackaging Systems Market Report 2026
https://www.thebusinessresearchcompany.com/report/pharmacy-repackaging-systems-global-market-report
Temperature Controlled Pharmaceutical Containers Market Report 2026
Pharmaceutical Packaging Equipment Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
